Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
6.48
+0.40 (6.58%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $141.37 million as of July 22, 2026. Its market cap has decreased by -45.70% in one year.
Market Cap
141.37M
Enterprise Value
50.51M
1-Year Change
-45.70%
Ranking
Category
Stock Price
$6.48
ChartMarket Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $141.37M, a decrease of -58.68%. That is a compound annual growth rate of -45.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 141.37M | -50.53% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 143.29M |
| Tiziana Life Sciences | 138.36M |
| Cibus | 136.63M |
| ProMIS Neurosciences | 136.22M |
| Cue Biopharma | 130.88M |
| Fractyl Health | 128.51M |
| Genelux | 127.45M |
| enGene Therapeutics | 121.92M |